Cortex Pharmaceuticals, Inc. (AMEX: COR), a biopharmaceutical company, is focused on the discovery, development and commercialization of AMPAKINE molecules designed to treat human central nervous system diseases. These novel small molecule drugs represent usher a new approach to treating psychiatric disorders, neurological diseases and brain mediated breathing disorders. For further information, visit the Company’s web site at www.cortexpharm.com.
Cortex Pharmaceuticals, Inc. (AMEX: COR)
November 3, 2008 at 5:37am
Archives
Select A Month
